Event Overview:

The 2025 CBA-GP Biomedical Science Symposium, the largest gathering of Chinese biomedical scientists in the Greater Philadelphia area, will be held on February 8, 2025, in the western suburbs of Philadelphia. This event is hosted by the Chinese Biopharmaceutical Association, USA–Greater Philadelphia (CBA-GP), with co-sponsorship from three major North American Chinese academic organizations: Chinese American Diabetes Association (CADA), Chinese American Liver Society (CALS), and Chinese American Academy of Cardiology (CAAC)

This symposium will feature 50 distinguished Chinese professors, including two members of the National Academy of Medicine, 28 full professors, 12 associate professors, and 10 assistant professors, representing 17 renowned universities and research institutes across Pennsylvania, New Jersey, New York, and Maryland. These include the University of Pennsylvania, Temple University, Blumberg Institute, Rutgers University, New York University, Cornell University, Columbia University, Coriell Institute, Thomas Jefferson University, Drexel University, Villanova University, and the University of Maryland, etc.

The symposium will cover cutting-edge advancements and translational research in various biomedical fields, including aging and neuroscience, cardiovascular diseases, cancer, metabolic disorders, and infectious diseases. Many of the participating professors are also founders of biotech startups.

The event aims to foster collaboration across biomedical disciplines through academic presentations, panel discussions, and networking sessions. It seeks to explore breakthroughs in biopharmaceutical innovation and address key challenges in the field.

Venue:

The symposium will take place at the historic The Baldwin School, located at 701 W Montgomery Ave, Bryn Mawr, PA 19010, United States. This iconic castle-style building offers an elegant and inspiring atmosphere, ideal for stimulating creativity and collaboration.

Call for Sponsors:

Sponsorship opportunities are now open for organizations and individuals interested in advancing science and innovation in the U.S.-China biopharmaceutical industry. Sponsors can showcase their projects, products, or services through on-site booths, advertisements, company presentations, and face-to-face interactions with attendees. Sponsorship tiers include Diamond, Gold, Silver, and Bronze, each offering tailored benefits.

For sponsorship inquiries, please contact:

• Professor Ling Yang: ling.yang@cba-usa.org
• General inquiries: cba-gp@cba-usa.org

Currently, we have 17 sponsors for this symposium already. We look forward to partnering with you for this landmark event!

Registration Information:

Registration is now open on a first-come, first-served basis. The registration fee is:

• $200 (including dinner)
• $80 (excluding dinner)
  CBA-GP members and members of co-host organizations are eligible for 50% off. CBA-GP Membership registration for 2024-2025 is free. To register, please visit this link.

We warmly invite you to join us in this exciting and impactful event!

The Chinese Biopharmaceutical Association – Greater Philadelphia (CBA-GP) is thrilled to announce the upcoming 2024 Annual Conference, scheduled to take place on Saturday, September 14th, 2024, at Villanova University’s Connelly Center, located at 800 E Lancaster Ave, Villanova, PA 19085.

This year’s conference theme, “Bridging Traditions & Innovations: The Next Era of Biopharma,” highlights the critical intersections between established scientific principles and cutting-edge innovations that are shaping the future of the biopharmaceutical industry. The conference will bring together a distinguished group of professionals, scholars, and entrepreneurs from across the biopharma sector to engage in discussions and share insights on the latest developments and trends.

Session Topics:

1. Bio-Medical Science Frontiers
   Explore the latest advancements in biomedical sciences that are pushing the boundaries of what is possible in healthcare and medicine.
2. Global Vision of Present and Future for Bio-Medical Collaboration
   A forward-looking session discussing the global landscape of biomedical collaboration, with insights into future opportunities and challenges.
3. ADC Drug Development and Collaboration
   Delve into the intricacies of Antibody-Drug Conjugates (ADC) drug development and the collaborative efforts needed to bring these innovative therapies to market.
4. Entrepreneurship and Startup BootCamp Closing Ceremony
   Celebrate the conclusion of the Startup BootCamp with discussions on entrepreneurship in biopharma, highlighting the journey from innovative ideas to successful ventures.

This event promises to be a valuable opportunity for networking, learning, and collaboration. Whether you’re an established professional, a budding entrepreneur, or a student eager to learn more about the biopharma industry, this conference has something to offer.

Details:

• Date: Saturday, September 14th, 2024
• Location: Villanova University, Connelly Center
  800 E Lancaster Ave, Villanova, PA 19085
• Time: [Insert Time, if available]

To ensure your spot at this pivotal event, please register early. Scan the QR code on the event poster or Click Here to Register.

We look forward to welcoming you to what promises to be an enlightening and inspiring conference!

About CBA-GP

Established in February 2023, CBA-GP is the Greater Philadelphia chapter of the Chinese Biopharmaceutical Association, USA (CBA), one of the largest Chinese non-profit professional associations in the United States (https://cba-usa.org/about/chapters/cba-greater-philadelphia-cba-gp-2023/). The core team of CBA-GP comprises professors from academia and executives from the biopharmaceutical industry. CBA-GP is committed to promoting biotechnology innovation, product incubation, and commercialization, strengthening cooperation and connections between academia and industry, and providing guidance for professional development. CBA-GP has organized over ten online and offline events this year, covering topics such as career development, small business fund applications, and entrepreneurship in the biotechnology field. Currently, CBA-GP has around 1,700 members.